| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $46.50 | Nov 13, 2025 | Direct |
| Mineralys Therapeutics, Inc. | Director | Stock Option | 34K | Nov 13, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | Nov 11, 2025 | 13 | -$1.2M | 4 | Nov 13, 2025 | Director |
| MLYS | Mineralys Therapeutics, Inc. | Feb 13, 2025 | 1 | $0 | 4 | Feb 24, 2025 | Director |
| MLYS | Mineralys Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
| MLYS | Mineralys Therapeutics, Inc. | Jun 13, 2024 | 0 | $0 | 3 | Jun 17, 2024 | Director |